Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
Total Current Assets
Entera Bio Ltd
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Current Assets
$11.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Current Assets
$28m
|
CAGR 3-Years
70%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Current Assets
$157.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Total Current Assets
$47.2m
|
CAGR 3-Years
27%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Current Assets
$196.8m
|
CAGR 3-Years
28%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Current Assets
₪26.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
24%
|
CAGR 10-Years
15%
|
See Also
What is Entera Bio Ltd's Total Current Assets?
Total Current Assets
11.3m
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Total Current Assets amounts to 11.3m USD.
What is Entera Bio Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-2%
Over the last year, the Total Current Assets growth was -12%. The average annual Total Current Assets growth rates for Entera Bio Ltd have been 7% over the past three years , -2% over the past five years .